Pharmadule Morimatsu wins Chinese design order for modular MAb facility

Nacka, Stockholm: – Swedish-based designer and engineer for the pharma and biotech industries, Pharmadule Morimatsu AB (Pharmadule) has received an order from a Chinese corporation to execute a Conceptual & Basic Design study for a new Biopharmaceutical Monoclonal antibody (MAb) production facility project in China.

The extended study will involve engineering departments from Pharmadule’s Stockholm and Shanghai offices.

Modular solutions

The study will be completed during the first quarter of 2017. The scope of delivery includes Process, Facility, Quality and Regulatory disciplines.

Following close on the heels of an extended Conceptual Design study for a biopharmaceutical green field project in China, this latest project forms further proof of the global attractiveness of Pharmadule Morimatsu modular facility and process solutions and engineering services. The company won this order against intense competition from other International and well recognized engineering and equipment providers.

About Pharmadule Morimatsu

Pharmadule Morimatsu designs and builds turnkey production facilities and provides process equipment’s for the pharma/ biopharma & FMCG (Fast Moving Consumer Goods) Industries worldwide. Pharmadule services extend from conceptual design to IQ & OQ qualifications completion, offering a one-stop-shop suite of services that include: Front-End Design & Pre-Engineering, Detailed Design, Fabrication, Quality Assurance (QA) and Validation Management.

The company was founded in 1986, since when it has successfully delivered more than 70 production facilities worldwide for clients including Eli Lilly, Merck, Baxter, GlaxoSmithKline, Genentech, Pharmacia and AstraZeneca, forging The Pharmadule Way as a way of offering unique value and reassurance to customers, with off-site construction and modular design concepts to provide very high predictability of on time, on budget delivery and consistent high quality, regardless of final location.

Since 2011, Pharmadule has been part of the Morimatsu Group of Japan with more than 5000 employees, an international manufacturer of tanks, heat exchangers, process skids and modules – forming Pharmadule Morimatsu AB, headquartered in Stockholm, Sweden. The company also has a strong presence in Asia with engineering and manufacturing facilities in Shanghai, providing an enhanced service for clients in new markets.